NCT05531370

Brief Summary

This study aims to implement the evidence-based intervention breathing retraining into clinical care of patients with symptomatic asthma irrespective of asthma severity or comorbidities, and in a diverse multicentre setting to evaluate implementation outcomes. This will meet patients' needs and improve health and life situation in patients with uncontrolled asthma. Further, the study will evaluate implementation outcomes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable asthma

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2022

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

July 4, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 7, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

3.5 years

First QC Date

July 4, 2022

Last Update Submit

November 15, 2024

Conditions

Keywords

ImplementationAsthmaBreathing Retraining

Outcome Measures

Primary Outcomes (4)

  • Adoption of intervention (Uptake)

    Organization-related (Pulmonologists, general practioners, physiotherapists) outcome: Proportion of general practices and of hospitals that will adopt BR.

    Through study completion, an average of 1 year

  • Implementation of intervention (Fidelity)

    Organization-related (physiotherapists) outcome: % of contents delivered as planned assessed by a checklist of key aspects in the breathing retraining-intervention.

    Through study completion, an average of 1 year

  • Feasibility of online sessions in Hybrid delivery mode of BR (H-BR) (Acceptability)

    Patient- and Organization-related (physiotherapists) outcome: assessed by a semi-structured interview.

    Through study completion, an average of 1 year

  • Effectiveness: MiniAsthma Quality of Life Questionnaire, MiniAQLQ

    Patient-related outcome, disease specific quality of life questionnaire. 7-point Likert scales from 1-7, 1 = worse outcome, 7 = better outcome. Success rates of improvements minus deteriorations of individual effects, measured at 12 month follow up.

    Through study completion, an average of 1 year

Secondary Outcomes (4)

  • MiniAsthma Quality of Life Questionnaire, MiniAQLQ

    Change from baseline to 12 months

  • Breathing pattern observation

    Change from baseline to 12 month

  • Objective physical activity level

    Change from baseline to 12 month

  • Objective steps per day (average)

    Change from baseline to 12 month

Other Outcomes (4)

  • Ashma severity by Global Initiative for Asthma (GINA) treatment steps

    Change from baseline to 12 month

  • Adverse events (Safety)

    Post-intervention (3-month)

  • Asthma Control Questionnaire, ACQ5

    Change from baseline to 12 month

  • +1 more other outcomes

Study Arms (1)

Breathing Retraining (BR)

EXPERIMENTAL

Patients will receive three sessions (60 min, 30 min, 30 min) of breathing retraining (BR), 1-to-1 with a trained physiotherapist. As preferred by the patient: * Hybrid delivery mode of BR (H-BR): First session on-site at hospital/clinic for initial assessment and introduction, and following sessions online (MedComs VDX platform or equal; participants access using web cam and sound on smart phone, tablet, or pc). * Ordinary delivery of BR: Three sessions on-site at hospital/clinic.

Other: Breathing Retraining

Interventions

Conforming the real-world setting, all participants will continue standard asthma care, i.e., acute and planned visits at GP or pulmonologist. BR aims to normalize the inhaled volume, nasal inhalation, exhalation to the resting position of the chest (functional residual capacity, FRC), use of the diaphragm muscle, and to move lower parts of the chest in a frequency of 12-16 per minute. This pattern is initially trained in rest (e.g., side lying or sitting), then during physical activity (e.g., walking). Uncontrolled coughing, frequent yawning or sighing is handled by a suppression technique. Relaxation technique is introduced as a separate activity but to be combined with the breathing pattern method to be used in both resting and as possible during physical activity.

Also known as: Breathing Exercises
Breathing Retraining (BR)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Doctor diagnosed asthma;
  • Incompletely controlled asthma or worse: Asthma Control Questionnaire (ACQ5) score ≥0.8;
  • Residence (or asthma treatment program) in Region Zealand, Denmark;
  • Able to read and understand Danish or available assistance to help understand information material, intervention content and respond to questionnaires.

You may not qualify if:

  • Unwilling to participate;
  • Unable to participate in the intervention due to physical or mental condition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Naestved Hospital

Næstved, Region Sjælland, 4700, Denmark

Location

MeSH Terms

Conditions

Asthma

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Søren T Skou, Prof.

    Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark

    STUDY CHAIR
  • Lars H Tang, Assoc.Prof.

    Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark

    STUDY CHAIR
  • Cecilie L Egholm, PostDoc.

    Naestved-Slagelse-Ringsted Hospitals, Denmark

    STUDY CHAIR
  • Uffe Bodtger, Prof.

    Zealand University Hospital; University of Southern Denmark

    STUDY CHAIR
  • Mike Thomas, Prof.

    Primary Care Research University of Southampton, UK

    STUDY CHAIR
  • Karen H Andreasson, Dr.

    Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2022

First Posted

September 7, 2022

Study Start

June 30, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

November 19, 2024

Record last verified: 2024-11

Locations